Clinical Trial

Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease

Study acronym: PIEDIABETICO
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a randomized clinical trial that compares the effectiveness of Plasma Rich in Growth Factors (PRGF) with conventional treatment for healing foot ulcers in diabetic patients who also have peripheral arterial disease. The goal is to assess how well PRGF promotes healing over a six-month period.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-23; most recent amendment 2025-09-10.
Trial Details
NCT Number NCT06952998
Lead Sponsor Biotechnology Institute IMASD
Collaborators: Hospital de Basurto
Conditions Foot Ulcers, Diabetic
Enrollment 38 participants
Start Date 2025-11-01
Primary Completion 2026-05-30 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-11